High miR‐202‐5p Expression at Initial Diagnosis is Associated With Tyrosine Kinase Inhibitor Resistance In Chronic Myeloid Leukemia—A Result From a Nested Case‐Control Study

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2026-02-01
DOI
https://doi.org/10.1002/jha2.70240
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High miR‐202‐5p Expression at Initial Diagnosis is Associated With Tyrosine Kinase Inhibitor Resistance In Chronic Myeloid Leukemia—A Result From a Nested Case‐Control Study

Yi-Xiang Wang, Zi‐Yuan Nie, Tie‐Jun Gong, Ya‐Bei Zuo et al.
eJHaem
Chronic Myeloid Leukemia Treatments
article

High miR‐202‐5p Expression at Initial Diagnosis is Associated With Tyrosine Kinase Inhibitor Resistance In Chronic Myeloid Leukemia—A Result From a Nested Case‐Control Study

Yi-Xiang Wang, Zi‐Yuan Nie, Tie‐Jun Gong, Ya‐Bei Zuo, Jin‐Ao Li, Zi‐Yu Zhao
article en

Abstract

No abstract available for this paper.
eJHaemVol. 7(1)
Hebei Medical University (CN), Harbin Medical University (CN), Second Hospital of Hebei Medical University (CN), Harbin FRP Research Institute (CN), First Affiliated Hospital of Harbin Medical University (CN)
Natural Science Foundation of Hebei Province
Openalex Percentile: Top 57%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.